MENLO PARK, Calif. — An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has reportedly created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors an A.I. outbreak in Turkey in 2005.
These antibody libraries could prevent a pandemic and provide treatment to infected people, as well as potentially pointing the way toward the development of a universal flu vaccine, according to the company. The expanded treatment and containment options could help healthcare officials combat an A.I. outbreak.
Read the full MeatPoultry.com story here.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report
